Search

everythinglearnresearchcommunity

for

Search:↓

The study developed a method to detect minoxidil and its sulfate form, found that minoxidil sulfate is temperature-sensitive, and identified a way to potentially increase its stability for hair loss treatment.

A new mutation caused a rare hair disorder in a Polish girl, not inherited from her family.

A new compound was made to detect copper ions effectively.

Some birth control pills can cause temporary or more serious hair loss.

Smaller nanoparticles improve minoxidil absorption through hair follicles.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

DNA methylation of miR-365-1 causes hair follicle stem cell death by affecting DAP3.

Scientists created a gel with nanoparticles to deliver medicine to hair follicles effectively.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

Combination therapy with QR 678 Neo and 5% Minoxidil is most effective for male hair loss.

Progesterone and allopregnanolone increase glycine release in rat brain cells.

New progesterone-based compounds can block male hormones.

New mutations in hair keratin genes cause the rare hair disorder monilethrix.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.

The document's conclusion cannot be provided because the document is not available or cannot be read.

Methylation of the 5-AR2 gene may cause resistance to Finasteride in BPH patients.

Zouboulis syndrome is a rare condition that helps diagnose monosomy 18p early.

Human liver enzyme DHEA ST helps process minoxidil.

A 6-year-old girl was diagnosed with a rare hair disorder and started treatment with topical minoxidil.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

MOF controls key genes for skin development by regulating mitochondrial and ciliary functions.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

m6A deregulation plays a key role in PCOS and could lead to new treatments.

A new nanozyme using EGCG and L-arginine boosts hair growth by safely increasing beneficial oxidative stress.

4-O-Methylhonokiol helps protect skin cells from growth-stopping effects of a protein by regulating growth-related pathways.

Scientists discovered a new way UVB light increases skin pigmentation through the ATP-P2X7 pathway.

The enzyme system in hair follicles is similar to the liver's and is affected by certain inhibitors.